Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats.
The mechanisms of hepatocarcinogenesis by certain synthetic estrogens seem to involve both nongenotoxic and indirect genotoxic effects. However, the natural estrogen estradiol did not exert any carcinogenic effects in established experimental protocols. To elucidate specific long-term effects of natural estrogens on hepatocytes, small pieces of ovarian tissue were transplanted via the portal vein into the livers of ovariectomized female rats. One week, 3 weeks, and 3 months after transplantation the transplants were found to proliferate and to secrete estradiol. Three weeks after transplantation the hepatocytes of the liver acini downstream of the stimulated transplants already showed a remarkable loss of glycogen, distinct cytoplasmic amphophilia, enlargement of their nuclei, a strong increase in the number and size of peroxisomes, an increase in proliferative activity and apoptotic elimination, and changes in the activity of certain key enzymes of energy metabolism. All hepatocellular alterations could be inhibited by the estrogen receptor antagonist toremifene and are, therefore, attributed to specific effects of estradiol produced by the transplants. The observed alterations resemble in some respects amphophilic preneoplastic liver foci, which particularly occur after long-term administration of nongenotoxic hepatocarcinogens, including the adrenal steroid hormone dehydroepiandrosterone. In a preliminary experiment three of six animals exhibited a hepatocellular carcinoma, and another animal developed a hepatocellular adenoma 18 months after intrahepatic ovarian tissue transplantation.
Klotz
L
L
Pathologisches Institut, Universität Bonn, Bonn, Germany.
Hacker
H J
HJ
Klingmüller
D
D
Bannasch
P
P
Pfeifer
U
U
Dombrowski
F
F
D000236:Adenoma / Q000473:pathology; D000818:Animals; D002455:Cell Division; D004798:Enzymes / Q000378:metabolism; D004967:Estrogens / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006651:Histocytochemistry; D008099:Liver / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D008113:Liver Neoplasms / Q000473:pathology; D007986:Luteinizing Hormone / Q000097:blood; D010052:Ovariectomy; D010053:Ovary / Q000473:pathology / Q000637:transplantation*; D011374:Progesterone / Q000097:blood; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D015430:Weight Gain
D004798:Enzymes; D004967:Estrogens; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone